Affymetrix to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference

  
    
  
  
    
      Affymetrix Inc. (NASDAQ:AFFX) today announced that John Batty, executive 
      vice president and chief financial officer, will provide a company 
      overview at the Merrill Lynch Global Pharmaceutical, Biotechnology & 
      Medical Device Conference on February 7th in New York City. A live 
      webcast of the presentation will take place at 8:40 a.m. ET.
    
    
      To access both the live and archived webcasts, please go to www.affymetrix.com 
      and click on the "Investors" link under the “Resources 
      for” dropdown. An archived webcast of the 
      presentation will be available for 30 days.
    
    
      About Affymetrix
    
    
      Affymetrix GeneChip(R) microarray technology is the industry-standard 
      tool for analyzing complex genetic information. After inventing 
      microarray technology in the late 1980s, Affymetrix scientists have been 
      dedicated to developing innovative products that provide researchers 
      with a more complete view of the genome. These products continue to 
      accelerate genetic research and enable scientists to develop diagnostics 
      and tailor treatments for individual patients by identifying and 
      measuring the genetic information associated with complex diseases.
    
    
      Today, Affymetrix technology is used by the world's top pharmaceutical, 
      diagnostic and biotechnology companies, as well as leading academic, 
      government and not-for-profit research institutes. More than 1,600 
      systems have been shipped around the world and more than 10,600 
      peer-reviewed papers have been published using the technology.
    
    
      Affymetrix is headquartered in Santa Clara, Calif., and has 
      manufacturing facilities in Sacramento, Calif., and Singapore. The 
      company has about 1,100 employees worldwide and maintains sales and 
      distribution operations across Europe and Asia. For more information 
      about Affymetrix, please visit the company's website at www.affymetrix.com.
    
    
      NOTE: Affymetrix, the Affymetrix logo and GeneChip(R) are registered 
      trademarks owned or used by Affymetrix Inc.